Clinical Trials Directory

Trials / Unknown

UnknownNCT04233320

Efficacy and Safety of Silicone Cream Containing Allium Cepa Extract

Efficacy and Safety of Silicone Cream Containing Allium Cepa Extract in Post-cesarean Surgical Scars Treatment

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
22 (estimated)
Sponsor
Chulalongkorn University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The objectives of this study were to evaluate efficacy and safety of silicone cream containing Allium Cepa extract in post-cesarean surgical scars treatment. Post-cesarean surgical scars were equally seperated into 2 parts (left part and right part). Silicone cream containing Allium Cepa extract or commercial scar gel was ramdomly assigned to apply on left part or right part of the scar. They will be applied 2 times per day (morning and evening) for 3 months. Patient and Observer Scar Assessment Scale (POSAS) , Vancouver scar scale (VSS), melanin index, and erythema index (using cutometer) were used for scar evaluation at 0, 1,2,and 3 months. Moreover, adverse effects were also observed.

Conditions

Interventions

TypeNameDescription
DEVICEsilicone cream containing Allium Cepa extractsilicone cream containing Allium Cepa extract contains 10% of Allium cepa bulb extract.
DEVICECommercial scar gelCommercial scar gel is a topical silicone gel. It contains cyclic and polymeric siloxanes and Vitamin C ester.

Timeline

Start date
2020-02-01
Primary completion
2020-06-30
Completion
2020-09-30
First posted
2020-01-18
Last updated
2020-01-21

Source: ClinicalTrials.gov record NCT04233320. Inclusion in this directory is not an endorsement.